Open Access Green as soon as Postprint is submitted to ZB.
Shortening the paths to type 1 diabetes mellitus prevention.
Nat. Rev. Endocrinol. 17, 73–74 (2021)
The development and application of effective immunotherapies for type 1 diabetes mellitus has lagged behind our ability to identify and stage individuals in pre-clinical stages of disease. This Year in Review addresses advances in immunotherapy aimed towards prevention and our readiness to roll out screening in the broader population.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Editorial
ISSN (print) / ISBN
1759-5029
e-ISSN
1759-5037
Journal
Nature Reviews - Endocrinology
Quellenangaben
Volume: 17,
Pages: 73–74
Publisher
Nature Publishing Group
Publishing Place
New York, NY
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute for Pancreatic Beta Cell Research (IPI)
Institute of Diabetes and Obesity (IDO)
Institute of Diabetes Research Type 1 (IDF)
Institute of Diabetes and Obesity (IDO)
Institute of Diabetes Research Type 1 (IDF)